Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs03458554
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
TWN | (3S)-3-[(2S,3S,4R)-3,4-DIMETHYLTETRAHYDROFURAN- 2-YL]BUTYL LAURATE | A,B | 2IVD | 0.7 | |
TWN | (3S)-3-[(2S,3S,4R)-3,4-DIMETHYLTETRAHYDROFURAN- 2-YL]BUTYL LAURATE | A,B | 2IVE | 0.7 | |
L2C | (2S)-3-HYDROXY-2-(NONANOYLOXY)PROPYL LAURATE | A,C | 2HVK | 0.72 | |
L2C | (2S)-3-HYDROXY-2-(NONANOYLOXY)PROPYL LAURATE | A,C | 2DWD | 0.72 | |
L2C | (2S)-3-HYDROXY-2-(NONANOYLOXY)PROPYL LAURATE | C | 2DWE | 0.72 | |
L2C | (2S)-3-HYDROXY-2-(NONANOYLOXY)PROPYL LAURATE | A,C | 2HVJ | 0.72 | |
ERY | ERYTHROMYCIN A | A,B | 2IYF | 0.71 | |
ERY | ERYTHROMYCIN A | A,B | 3FRQ | 0.71 | |
ERY | ERYTHROMYCIN A | 0,1,2,3,9,A, B,C,H,J,K,L, M,N,O,Q,R,S, T,U,Y,Z | 1YI2 | 0.71 | |
ERY | ERYTHROMYCIN A | A,B | 2J0D | 0.71 | |
ERY | ERYTHROMYCIN A | A | 1JZY | 0.71 | |
DGA | DIACYL GLYCEROL | A,C | 2NLJ | 0.71 | |
DGA | DIACYL GLYCEROL | A,C | 1ZWI | 0.71 | |
DGA | DIACYL GLYCEROL | B,C | 1R3J | 0.71 | |
DGA | DIACYL GLYCEROL | C | 1K4D | 0.71 | |
DGA | DIACYL GLYCEROL | A,C | 1K4C | 0.71 | |
DGA | DIACYL GLYCEROL | C | 1R3K | 0.71 | |
DGA | DIACYL GLYCEROL | B,C | 1S5H | 0.71 | |
DGA | DIACYL GLYCEROL | C,H | 1R3I | 0.71 | |
DGA | DIACYL GLYCEROL | B,C | 1R3L | 0.71 | |
DGG | 1-[GLYCEROLYLPHOSPHONYL]-2-[8-(2- HEXYL-CYCLOPROPYL)-OCTANAL-1-YL]- 3-[HEXADECANAL-1-YL]-GLYCEROL | A,B | 1CQX | 0.71 | |
FOK | FORSKOLIN | A,C | 3C16 | 0.72 | |
FOK | FORSKOLIN | A,C | 1CJU | 0.72 | |
FOK | FORSKOLIN | A,C | 1TL7 | 0.72 | |
FOK | FORSKOLIN | A,B | 1AB8 | 0.72 | |
FOK | FORSKOLIN | A,C | 3C14 | 0.72 | |
FOK | FORSKOLIN | A,C | 1CJT | 0.72 | |
FOK | FORSKOLIN | A,B,C | 1CUL | 0.72 | |
FOK | FORSKOLIN | A,C | 1CJV | 0.72 | |
FOK | FORSKOLIN | A,C | 3C15 | 0.72 | |
FOK | FORSKOLIN | A,C | 1U0H | 0.72 | |
FOK | FORSKOLIN | A,B,C | 1CS4 | 0.72 | |
FOK | FORSKOLIN | A,C | 1CJK | 0.72 | |
E7B | A,B | 3E7B | 0.71 | ||
13T | 13-DEOXYTEDANOLIDE | 0,1,3,9,A,B, C,H,J,K,L,M, N,O,Q,R,S,T, U,Y,Z | 2OTJ | 0.72 | |
DQA | 1,3,4-TRIHYDROXY-5-OXO-CYCLOHEXANECARBOXYLIC ACID | A | 1J2Y | 0.78 | |
LIL | 2-TRIDECANOYLOXY-PENTADECANOIC ACID | A | 2FCP | 0.72 | |
LIL | 2-TRIDECANOYLOXY-PENTADECANOIC ACID | A | 1FCP | 0.72 | |
DEB | 6-DEOXYERYTHRONOLIDE B | A | 1Z8P | 0.91 | |
DEB | 6-DEOXYERYTHRONOLIDE B | A | 1JIO | 0.91 | |
DEB | 6-DEOXYERYTHRONOLIDE B | A | 1Z8Q | 0.91 | |
DEB | 6-DEOXYERYTHRONOLIDE B | A | 1OXA | 0.91 | |
DEB | 6-DEOXYERYTHRONOLIDE B | A | 1Z8O | 0.91 | |
F24 | (3R,5S,7R,12S,13R)-13-FORMYL-12,14- DIHYDROXY-3,5,7-TRIMETHYLTETRADECANOIC ACID | A | 2F9A | 0.78 | |
DDR | (2S)-3-hydroxypropane-1,2-diyl didecanoate | A | 2Z9Y | 0.72 | |
DDR | (2S)-3-hydroxypropane-1,2-diyl didecanoate | A | 2Z9Z | 0.72 | |
1EM | (1S)-2-HYDROXY-1-[(NONANOYLOXY)METHYL]ETHYL MYRISTATE | C | 2IH1 | 0.72 | |
1EM | (1S)-2-HYDROXY-1-[(NONANOYLOXY)METHYL]ETHYL MYRISTATE | C | 2IH3 | 0.72 | |
1EM | (1S)-2-HYDROXY-1-[(NONANOYLOXY)METHYL]ETHYL MYRISTATE | A,C | 2P7T | 0.72 | |
CTY | CLARITHROMYCIN | A | 1J5A | 0.71 | |
CRB | [1R-(1ALPHA,3BETA,4ALPHA,5BETA)]- 5-(PHOSPHONOMETHYL)-1,3,4-TRIHYDROXYCYCLOHEXANE- 1-CARBOXYLIC ACID | A,B | 1XAI | 0.71 | |
CRB | [1R-(1ALPHA,3BETA,4ALPHA,5BETA)]- 5-(PHOSPHONOMETHYL)-1,3,4-TRIHYDROXYCYCLOHEXANE- 1-CARBOXYLIC ACID | A,B | 1NVD | 0.71 | |
CRB | [1R-(1ALPHA,3BETA,4ALPHA,5BETA)]- 5-(PHOSPHONOMETHYL)-1,3,4-TRIHYDROXYCYCLOHEXANE- 1-CARBOXYLIC ACID | A | 1XAG | 0.71 | |
CRB | [1R-(1ALPHA,3BETA,4ALPHA,5BETA)]- 5-(PHOSPHONOMETHYL)-1,3,4-TRIHYDROXYCYCLOHEXANE- 1-CARBOXYLIC ACID | A,B | 1NR5 | 0.71 | |
CRB | [1R-(1ALPHA,3BETA,4ALPHA,5BETA)]- 5-(PHOSPHONOMETHYL)-1,3,4-TRIHYDROXYCYCLOHEXANE- 1-CARBOXYLIC ACID | A,B | 1XAJ | 0.71 | |
CRB | [1R-(1ALPHA,3BETA,4ALPHA,5BETA)]- 5-(PHOSPHONOMETHYL)-1,3,4-TRIHYDROXYCYCLOHEXANE- 1-CARBOXYLIC ACID | A,B | 1XAL | 0.71 | |
CRB | [1R-(1ALPHA,3BETA,4ALPHA,5BETA)]- 5-(PHOSPHONOMETHYL)-1,3,4-TRIHYDROXYCYCLOHEXANE- 1-CARBOXYLIC ACID | A,B | 1DQS | 0.71 | |
CRB | [1R-(1ALPHA,3BETA,4ALPHA,5BETA)]- 5-(PHOSPHONOMETHYL)-1,3,4-TRIHYDROXYCYCLOHEXANE- 1-CARBOXYLIC ACID | A,B | 1NVB | 0.71 | |
CRB | [1R-(1ALPHA,3BETA,4ALPHA,5BETA)]- 5-(PHOSPHONOMETHYL)-1,3,4-TRIHYDROXYCYCLOHEXANE- 1-CARBOXYLIC ACID | A,B,C | 1NVF | 0.71 | |
B3H | (2S)-2-(BUTYRYLOXY)-3-HYDROXYPROPYL NONANOATE | C,D | 2HFE | 0.71 | |
B3H | (2S)-2-(BUTYRYLOXY)-3-HYDROXYPROPYL NONANOATE | C,D | 2H8P | 0.71 | |
B3H | (2S)-2-(BUTYRYLOXY)-3-HYDROXYPROPYL NONANOATE | C,D | 2HG5 | 0.71 |